Structural characterization of tatiopterin, a novel pterin isolated from Methanogenium tationis.

Cofactor extracts of Methanogenium tationis were screened for the presence of pterin-derivatives. Methanopterin, sarcinapterin and 7-methylpterin were absent, while 2-amino-4-hydroxy-pteridine and another blue fluorescent compound with a pterin spectrum were detected. The latter pterin was purified by ion exchange and reversed-phase column chromatography. The structure of this compound was elucidated by combining spectrophotometry, amino acid analysis and 1H-NMR spectroscopy. The pterin, which we named tatiopterin, was identified as an aspartyl derivative of sarcinapterin with a 7-proton instead of a 7-methyl group in the pterin moiety. The IUPAC name is: N-[-1'-(2''-amino-4''-hydroxy-7''-proton-6''-pteridinyl)ethyl]-4- [2',3',4',5'-tetrahydroxypent-1'-yl(5'----1'')O-alpha- ribofuranosyl-5''-phosphoric acid]aniline, in which the phosphate group is esterified with alpha-hydroxyglutarylglutamylaspartic acid.

[1]  P. De Baetselier,et al.  Generation of invasive and metastatic variants of a non‐metastatic T‐cell lymphoma by in vivo fusion with normal host cells , 1984, International journal of cancer.

[2]  A. Partin,et al.  Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. , 1988, Cancer research.

[3]  M. Mareel,et al.  Tumour invasion and metastasis: therapeutic implications? , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  R. D. De Abreu,et al.  In vitro inhibition of cell growth of MOLT-4 malignant human T-lymphoblasts by coenzyme F420. , 1991, Biochemical pharmacology.

[5]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[6]  P. Rouvière,et al.  Novel biochemistry of methanogenesis. , 1988, The Journal of biological chemistry.

[7]  A. Partin,et al.  Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. , 1988, Cancer research.

[8]  D. Tempest,et al.  'Glutamine(amide):2-oxoglutarate amino transferase oxido-reductase (NADP); an enzyme involved in the synthesis of glutamate by some bacteria. , 1970, Journal of general microbiology.

[9]  L. Liotta,et al.  Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration , 1987, Nature.

[10]  I. Yamamoto,et al.  COMPARISON OF PROPERTIES OF GLUTAMATE DEHYDROGENASES IN MEMBERS OF THE BACTEROIDES FRAGILIS GROUP , 1987 .

[11]  G. Vogels,et al.  Proposed structure for coenzyme F420 from Methanobacterium. , 1978, Biochemistry.

[12]  R. Thauer,et al.  7‐Mercaptoheptanoylthreonine phosphate functions as component B in ATP‐independent methane formation from methyl‐CoM with reduced cobalamin as electron donor , 1987, FEBS letters.

[13]  M. Mareel,et al.  Action mechanisms of anti-invasive agents. , 1986, Anticancer research.

[14]  J. Varani.  Interaction of tumor cells with the extracellular matrix. , 1987, Revisiones sobre biologia celular : RBC.

[15]  G. Storme,et al.  Modification of cell surface carbohydrates and invasive behavior by an alkyl lysophospholipid. , 1988, Cancer research.

[16]  H. König,et al.  Emended description of Methanogenium thermophilicum, Rivard and Smith, and assignment of new isolates to this species , 1985 .

[17]  W. Jencks,et al.  The dissociation constants of tetrahydrofolic acid. , 1966, The Journal of biological chemistry.

[18]  C. Woese,et al.  Methanogens: reevaluation of a unique biological group , 1979, Microbiological reviews.

[19]  G. Vogels,et al.  Separation and quantification of cofactors from methanogenic bacteria by high-performance liquid chromatography: optimum and routine analyses , 1988 .

[20]  W. Whitman,et al.  Activation of the methylreductase system from Methanobacterium bryantii by ATP , 1983, Journal of bacteriology.